leisure time -WSS

leisure time

author：focus 2025-09-27 16:46:56 - browse：6386

Verve Therapeutics CEO Sekar Kathiresan Verve

SAN FRANCISCO — The promise of genome editing has given rise to potentially curative medicines for rare, life-threatening diseases that generally affect small numbers of patients. But since Verve Therapeutics was founded in 2018, it’s had a wider aperture: using the molecular tools of genome editing to go after the most common cause of death in the world.

The plan, according to Verve CEO Sekar Kathiresan, is to edit out heart attacks for the millions of people at risk for severe cardiovascular disease. It’s a goal that’s more than a little audacious. There’s just one approved genome editing medicine, a treatment for sickle cell disease, and it only passed Food and Drug Administration review last month. Base editing, the CRISPR successor Verve uses to conduct its molecular surgery, is only a few years old.

“When we started, there were so many things that we were kind of going against the grain on,” Kathiresan told STAT at the J.P. Morgan Healthcare Conference in San Francisco this week. “In 2018, it was all about platforms, not about specific diseases and products, or taking this kind of idea for a large indication as opposed to cancer or rare disease. But we’ve always been motivated by a deep conviction in one simple research insight, which is that if your blood cholesterol is really low, lifelong, it is very hard to get a heart attack.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Mike Pence clashes with Tucker Carlson in Iowa

WSS

J&J expands global access to TB drug amid advocacy campaign

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

NVIDIA and Google execs on the future of AI and drug discovery

Cytokinetics CEO stresses company can launch heart drug on its own

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Case highlights the risks of experimental stem cell therapy

Wikipedia

leisure time

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Medical records are filled with copy

Grail faces three suits alleging harassment, retaliation

23andMe had bad news about my health. I wish a person had delivered it

Readers respond to H5N1 and livestock movements, and more

Activists slam private health insurers over coverage restrictions

Wearables generate powerful data but its not useful to doctors, yet

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

When prostate cancer spreads, where it goes matters

focus

Georgia court denies Trump's request to quash DA's 2020 election probe

Military medical care influenced by rank and race, new study finds

Congress: Eradicate hepatitis C and reduce the deficit

Addiction experts warn against a second 'war on drugs'

Venture capitalist Bob Kocher on the state of digital health

Europe sees delivery challenges ahead on Alzheimer's therapies

focus

Wikipedia

focus

leisure time